Inventiva intends to use the proceeds to fund part of its ongoing pivotal NATiV3 Phase III clinical trial evaluating lanifibranor in patients with NASH.This second tranche carries an interest rate of 7% annually and has
U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining over 100 points on Wednesday.
The Dow traded up 0.29% to 37,633.43 while the NASDAQ rose 0.72% to 14,965.31. The S&P 500 also rose, gaining, 0.48% to 4,779.31.
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining around 50 points on Wednesday.
The Dow traded up 0.17% to 37,588.15 while the NASDAQ rose 0.34% to 14,908.42. The S&P 500 also rose, gaining, 0.21% to 4,766.64.
U.S. stocks traded higher this morning, with the Dow Jones index gaining over 100 points on Wednesday.
Following the market opening Wednesday, the Dow traded up 0.27% to 37,627.83 while the NASDAQ rose 0.24% to 14,893.51. The S&P 500 also rose, gaining, 0.23% to 4,767.44.
The Saloon, a vehicle with a design echoing futuristic aesthetics, will be the first 0 Series model to grace North American shores. The Space-Hub, a larger vehicle concept, follows the Saloon's design ethos.
FAA has declared that the aircraft manufacturing giant Boeing will modify its inspection guidelines for the 737 Max 9 airplanes, in response to a mid-flight panel blowout incident that occurred last week.
Clinical-stage biopharma company Cybin Inc. (NYSE: CYBN) announced positive safety and efficacy data from its Phase 1 studies of CYB004 (intravenous administration) and SPL028 (intravenous and intramuscular administration) in healthy volunteers.
U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite turning higher on Tuesday.
The Dow traded down 0.53% to 37,484.13 while the NASDAQ rose 0.15% to 14,866.50. The S&P 500 also fell, dropping, 0.17% to 4,755.48.